These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9614371)

  • 1. Pulmonary adenocarcinoma: classification and molecular biology.
    Carey FA
    J Pathol; 1998 Mar; 184(3):229-30. PubMed ID: 9614371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung.
    Cooper CA; Carby FA; Bubb VJ; Lamb D; Kerr KM; Wyllie AH
    J Pathol; 1997 Apr; 181(4):401-4. PubMed ID: 9196437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stepwise progression of pulmonary adenocarcinoma--clinical and molecular implications.
    Noguchi M
    Cancer Metastasis Rev; 2010 Mar; 29(1):15-21. PubMed ID: 20108111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
    Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
    Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.
    Wislez M; Spencer ML; Izzo JG; Juroske DM; Balhara K; Cody DD; Price RE; Hittelman WN; Wistuba II; Kurie JM
    Cancer Res; 2005 Apr; 65(8):3226-35. PubMed ID: 15833854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
    Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
    Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Classification of broncho-pulmonary cancers (WHO 1999)].
    Brambilla E
    Rev Mal Respir; 2002 Sep; 19(4):455-66. PubMed ID: 12417862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary preinvasive neoplasia.
    Kerr KM
    J Clin Pathol; 2001 Apr; 54(4):257-71. PubMed ID: 11304841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The new classification of lung adenocarcinoma].
    Petersen I
    Zentralbl Chir; 2013 Oct; 138 Suppl 1():S16-24. PubMed ID: 24150851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors.
    Takeuchi T; Tomida S; Yatabe Y; Kosaka T; Osada H; Yanagisawa K; Mitsudomi T; Takahashi T
    J Clin Oncol; 2006 Apr; 24(11):1679-88. PubMed ID: 16549822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary preneoplasia--sequential molecular carcinogenetic events.
    Lantuéjoul S; Salameire D; Salon C; Brambilla E
    Histopathology; 2009 Jan; 54(1):43-54. PubMed ID: 19187179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung.
    Mori M; Rao SK; Popper HH; Cagle PT; Fraire AE
    Mod Pathol; 2001 Feb; 14(2):72-84. PubMed ID: 11235908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung.
    Licchesi JD; Westra WH; Hooker CM; Herman JG
    Clin Cancer Res; 2008 May; 14(9):2570-8. PubMed ID: 18451218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atypical adenomatous hyperplasia of the lung].
    Paklina OV; Galil-Ogly GA; Bershchanskaia AM; Alipchenko LA
    Arkh Patol; 2000; 62(3):21-4. PubMed ID: 10897432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
    Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
    J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
    Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
    Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precursor lesions of adenocarcinoma lung--two case reports.
    Jain D; Joshi K; Jindal SK
    Indian J Pathol Microbiol; 2005 Jul; 48(3):399-402. PubMed ID: 16761769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal numerical abnormalities in early stage lung adenocarcinoma.
    Sano T; Kitayama Y; Igarashi H; Suzuki M; Tanioka F; Chida K; Okudela K; Sugimura H
    Pathol Int; 2006 Mar; 56(3):117-25. PubMed ID: 16497244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is high-grade adenomatous hyperplasia an early bronchioloalveolar adenocarcinoma?
    Ullmann R; Bongiovanni M; Halbwedl I; Fraire AE; Cagle PT; Mori M; Papotti M; Popper HH
    J Pathol; 2003 Nov; 201(3):371-6. PubMed ID: 14595748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.